193 related articles for article (PubMed ID: 38646957)
21. A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology.
Singarayer R; Mete O; Perrier L; Thabane L; Asa SL; Van Uum S; Ezzat S; Goldstein DP; Sawka AM
Endocr Pathol; 2019 Sep; 30(3):201-218. PubMed ID: 31300997
[TBL] [Abstract][Full Text] [Related]
22. Analysis of metabolomics profile in hypothyroid patients before and after thyroid hormone replacement.
Piras C; Pibiri M; Leoni VP; Balsamo A; Tronci L; Arisci N; Mariotti S; Atzori L
J Endocrinol Invest; 2021 Jun; 44(6):1309-1319. PubMed ID: 33025552
[TBL] [Abstract][Full Text] [Related]
23. (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.
Niu QY; Li ZY; Du GH; Qin XM
J Pharm Biomed Anal; 2016 Jan; 118():338-348. PubMed ID: 26595282
[TBL] [Abstract][Full Text] [Related]
24. Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach.
Farrokhi Yekta R; Rezaei Tavirani M; Arefi Oskouie A; Mohajeri-Tehrani MR; Soroush AR; Akbarzadeh Baghban A
Iran J Basic Med Sci; 2018 Nov; 21(11):1140-1147. PubMed ID: 30483387
[TBL] [Abstract][Full Text] [Related]
25. Oncometabolites as biomarkers in thyroid cancer: a systematic review.
Khatami F; Payab M; Sarvari M; Gilany K; Larijani B; Arjmand B; Tavangar SM
Cancer Manag Res; 2019; 11():1829-1841. PubMed ID: 30881111
[TBL] [Abstract][Full Text] [Related]
26. A Preliminary Nuclear Magnetic Resonance Metabolomics Study Identifies Metabolites that Could Serve as Diagnostic Markers of Major Depressive Disorder.
Badamasi IM; Maulidiani M; Lye MS; Ibrahim N; Shaari K; Stanslas J
Curr Neuropharmacol; 2022; 20(5):965-982. PubMed ID: 34126904
[TBL] [Abstract][Full Text] [Related]
27. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
28. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics and detection of colorectal cancer in humans: a systematic review.
Wang H; Tso VK; Slupsky CM; Fedorak RN
Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
[TBL] [Abstract][Full Text] [Related]
30. NMR-based metabolomics to select a surgical method for treating papillary thyroid carcinoma.
Wang B; Zhang LY; Wang SS; Yang YH; Zhao WX
Clinics (Sao Paulo); 2018 Nov; 73():e333. PubMed ID: 30462753
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study.
Miccoli P; Torregrossa L; Shintu L; Magalhaes A; Chandran J; Tintaru A; Ugolini C; Minuto MN; Miccoli M; Basolo F; Caldarelli S
Surgery; 2012 Dec; 152(6):1118-24. PubMed ID: 23158182
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics in severe traumatic brain injury: a scoping review.
Fedoruk RP; Lee CH; Banoei MM; Winston BW
BMC Neurosci; 2023 Oct; 24(1):54. PubMed ID: 37845610
[TBL] [Abstract][Full Text] [Related]
33. Metabolomics analysis of seminal plasma in patients with idiopathic Oligoasthenoteratozoospermia using high-resolution NMR spectroscopy.
Mumcu A; Karaer A; Dogan B; Tuncay G
Andrology; 2020 Mar; 8(2):450-456. PubMed ID: 31520509
[TBL] [Abstract][Full Text] [Related]
34. ¹H NMR-based metabolic profiling of human rectal cancer tissue.
Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL
Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801
[TBL] [Abstract][Full Text] [Related]
35. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics profiling of seminal plasma in obesity-induced asthenozoospermia.
Zhou YF; Hou YY; Ban Q; Zhang ML; Huang T; Ma B; Shi L; Zhang Q
Andrology; 2023 Oct; 11(7):1303-1319. PubMed ID: 36841993
[TBL] [Abstract][Full Text] [Related]
37. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue.
Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W
Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747
[TBL] [Abstract][Full Text] [Related]
38. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
39. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
40. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
